Blackstone Group Inc.
- SEC CIK
- 0001393818
- Latest filing
- Aug 14, 2026
APRE holding history
Aprea Therapeutics, Inc. in every 13F filed by Blackstone Group Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APRE overviewAll 13F holders of APREFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −830−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q4 2022 | 16,590 | $5.49K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 16,590 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 16,590 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 16,590 | $31.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 16,590 | $48.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 16,590 | $85.0K | <0.1% | +16,590 | New | Holders |